secwatch.observer — SEC 8-K summary
======================================

Issuer:     Profound Medical Corp. (PROF)
CIK:        0001628808
Form:       8-K
Filed at:   2025-11-12T23:59:59+00:00
Accession:  0001171843-25-007224
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Profound Medical signs exclusive distribution deal for TULSA-PRO in Australia, New Zealand
--------------------------------------------------------------------------------

- Exclusive distribution & supply agreement with Getz Healthcare for TULSA-PRO system in Australia and New Zealand.
- TULSA-PRO is an AI-powered, MRI-guided robotic system for real-time prostate ablation without surgery or radiation.
- Partnership leverages Getz Healthcare's established distribution network in the region.
- Profound also deploys direct sales in North America while partnering with strategic distributors internationally.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628808/000117184325007224/0001171843-25-007224-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628808/000117184325007224/f8k_111225.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-007224

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer